Muscle Dysfunction in COPD Mechanisms of striated muscle dysfunction during acute exacerbations of COPD

Gayan-Ramirez G, Decramer M. Mechanisms of striated muscle dysfunction during acute exacerbations of COPD. J Appl Physiol 114: 1291–1299, 2013. First published January 31, 2013; doi:10.1152/japplphysiol.00847.2012.—During acute exacerbations of chronic obstructive pulmonary disease (COPD), limb and respiratory muscle dysfunction develops rapidly and functional recovery is partial and slow. The mechanisms leading to this muscle dysfunction are not yet fully established. However, recent evidence has shown that several pathways involved in muscle catabolism, apoptosis, and oxidative stress are activated in the vastus lateralis muscle of patients during acute exacerbations of COPD, while those implicated in mitochondrial function are downregulated. These pathways may be targeted in different ways by factors related to exacerbations. These factors include enhanced systemic inflammation, oxidative stress, impaired energy balance, hypoxia, hypercapnia and acidosis, corticosteroid treatment, and physical inactivity. Data on the respiratory muscles are limited, but these muscles are undoubtedly overloaded during exacerbations. While they are also subjected to the same systemic elements as the limb muscles (except for inactivity), they also face a specific mechanical disadvantage caused by changes in lung volume during exacerbation. The latter will affect the ability to generate force by the foreshortening of the muscle (especially for the diaphragm), but also by altering rib orientation and motion (especially for the parasternal intercostals and the external intercostals). Because acute exacerbations of COPD are associated with an increase in both prevalence and severity of generalized muscle dysfunction, and both remain present even during recovery, early interventions to minimize muscle dysfunction during exacerbation are warranted. Although rehabilitation may be promising, other therapeutic strategies such as counterbalancing the adverse effects of exacerbations on skeletal muscle pathways may also be used.

[1]  Sally J. Singh,et al.  Neuromuscular stimulation of quadriceps in patients hospitalised during an exacerbation of COPD: a comparison of low (35 Hz) and high (50 Hz) frequencies. , 2013, Physiotherapy research international : the journal for researchers and clinicians in physical therapy.

[2]  J. Duarte,et al.  Mitochondrial signaling contributes to disuse muscle atrophy. , 2012, American journal of physiology. Endocrinology and metabolism.

[3]  I. Taylor,et al.  Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease , 2011, Postgraduate Medical Journal.

[4]  S. Powers,et al.  Mechanistic links between oxidative stress and disuse muscle atrophy. , 2011, Antioxidants & redox signaling.

[5]  Patrick D Mitchell,et al.  Hypoxemia in patients with COPD: cause, effects, and disease progression , 2011, International journal of chronic obstructive pulmonary disease.

[6]  C. Prefaut,et al.  Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study , 2011, European Respiratory Journal.

[7]  J. Roca,et al.  Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. , 2010, Respiratory medicine.

[8]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[9]  M. Mador,et al.  Exercise capacity in hamsters with elastase-induced emphysema compared to normal controls , 2010, Respiratory Physiology & Neurobiology.

[10]  M. Decramer,et al.  Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[11]  M. Polkey,et al.  Outpatient pulmonary rehabilitation following acute exacerbations of COPD , 2010, Thorax.

[12]  M. Tarnopolsky,et al.  Little change in markers of protein breakdown and oxidative stress in humans in immobilization-induced skeletal muscle atrophy. , 2010, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[13]  M. Decramer,et al.  Gene Expression Profiling in Vastus Lateralis Muscle During an Acute Exacerbation of COPD , 2010, Cellular Physiology and Biochemistry.

[14]  R. Balk Mechanical determinants of early acute ventilatory failure in COPD patients: a physiologic study , 2010 .

[15]  J. Thissen,et al.  Mechanisms of Muscle Atrophy Induced by Glucocorticoids , 2009, Hormone Research in Paediatrics.

[16]  Amie J. Dirks-Naylor,et al.  Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  C. Lundby,et al.  The response of human skeletal muscle tissue to hypoxia , 2009, Cellular and Molecular Life Sciences.

[18]  Stuart M Phillips,et al.  Alterations of protein turnover underlying disuse atrophy in human skeletal muscle. , 2009, Journal of applied physiology.

[19]  T. Wilson,et al.  Effect of acute inflation on the mechanics of the inspiratory muscles. , 2009, Journal of applied physiology.

[20]  A. Agustí,et al.  Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients , 2009, European Respiratory Journal.

[21]  A. Mancha,et al.  Nutritional State during COPD Exacerbation: Clinical and Prognostic Implications , 2009, Annals of Nutrition and Metabolism.

[22]  J. Steurer,et al.  Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. , 2009, The Cochrane database of systematic reviews.

[23]  P. Tesch,et al.  Skeletal muscle proteolysis in response to short-term unloading in humans. , 2008, Journal of applied physiology.

[24]  D. Freyssenet,et al.  Cellular and molecular events controlling skeletal muscle mass in response to altered use , 2008, Pflügers Archiv - European Journal of Physiology.

[25]  M. Decramer,et al.  Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients , 2007, European journal of clinical investigation.

[26]  B. Celli,et al.  Exacerbations of chronic obstructive pulmonary disease , 2007, European Respiratory Journal.

[27]  J. Barberà,et al.  Mitochondrial dysfunction in COPD patients with low body mass index , 2007, European Respiratory Journal.

[28]  M. Polkey,et al.  A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease , 2007, Respiratory research.

[29]  B. Celli,et al.  Impact of COPD exacerbations on patient-centered outcomes. , 2007, Chest.

[30]  D. O’Donnell,et al.  COPD exacerbations · 3: Pathophysiology , 2006, Thorax.

[31]  Thierry Troosters,et al.  Physical activity and hospitalization for exacerbation of COPD. , 2006, Chest.

[32]  W. Reid,et al.  Increased injury and intramuscular collagen of the diaphragm in COPD: autopsy observations , 2006, European Respiratory Journal.

[33]  M. Decramer,et al.  IL-8 administration does not result in skeletal muscle wasting in rats , 2006 .

[34]  C. Prefaut,et al.  From muscle disuse to myopathy in COPD: potential contribution of oxidative stress , 2005, European Respiratory Journal.

[35]  N. Murphy,et al.  Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation. , 2005, Respiratory medicine.

[36]  N. Ambrosino,et al.  Lung and respiratory muscle function at discharge from a respiratory intensive care unit. , 2005, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[37]  M. Martínez-García,et al.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005, Thorax.

[38]  M. Reid Response of the ubiquitin-proteasome pathway to changes in muscle activity. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[39]  John R Hurst,et al.  Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[40]  M. Decramer,et al.  Interleukin-6 Causes Myocardial Failure and Skeletal Muscle Atrophy in Rats , 2005, Circulation.

[41]  E. Wouters,et al.  Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation; a randomized controlled feasibility trial. , 2004, Clinical nutrition.

[42]  Thierry Troosters,et al.  Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. , 2004, Chest.

[43]  M. Delp,et al.  Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters , 2004, European Respiratory Journal.

[44]  C. Lundby,et al.  Oxidative DNA damage and repair in skeletal muscle of humans exposed to high-altitude hypoxia. , 2003, Toxicology.

[45]  M. Engelen,et al.  Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[46]  M. Decramer,et al.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I , 2003 .

[47]  C. Fracchia,et al.  Peripheral Muscle Strength Training in Bed‐Bound Patients with COPD Receiving Mechanical Ventilation: Effect of Electrical Stimulation. , 2003, Chest.

[48]  J. Wedzicha,et al.  COPD exacerbations: definitions and classifications , 2003, European Respiratory Journal.

[49]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[50]  M. Lewis Apoptosis as a potential mechanism of muscle cachexia in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[51]  S. Quintana,et al.  Mortality after hospitalization for COPD. , 2002, Chest.

[52]  J. Gea,et al.  Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[53]  M. Elliott,et al.  Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome , 2001, Thorax.

[54]  E. Wouters,et al.  Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations , 2001, Thorax.

[55]  N. Anthonisen,et al.  Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.

[56]  F. López‐Soriano,et al.  The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting. , 2000, European cytokine network.

[57]  R. Ferrari,et al.  Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes , 2000, Heart.

[58]  T. Seemungal,et al.  Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels , 2000, Thrombosis and Haemostasis.

[59]  R. Rodríguez-Roisín,et al.  Toward a consensus definition for COPD exacerbations. , 2000, Chest.

[60]  E. Wouters,et al.  Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[61]  Who Consultation on Obesity Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.

[62]  J. Thissen,et al.  Regulation of IGF‐I, IGFBP‐4 and IGFBP‐5 gene expression by loading in mouse skeletal muscle , 1999, FEBS letters.

[63]  P. Mozdziak,et al.  Myogenin, MyoD, and myosin heavy chain isoform expression following hindlimb suspension. , 1999, Aviation, space, and environmental medicine.

[64]  M. Decramer,et al.  Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius. , 1999, American journal of respiratory and critical care medicine.

[65]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[66]  E. Wouters,et al.  Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. , 1997, The European respiratory journal.

[67]  J. Martin,et al.  Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.

[68]  R E Grindeland,et al.  Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. , 1997, The American journal of physiology.

[69]  W. MacNee,et al.  Prognostic significance of plasma D-dimer levels in patients with lung cancer. , 1997, Thorax.

[70]  J. Barberà,et al.  Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. , 1997, The European respiratory journal.

[71]  M. Mador,et al.  Effect of acute hypercapnia on diaphragmatic and limb muscle contractility. , 1997, American journal of respiratory and critical care medicine.

[72]  M. Decramer,et al.  Muscle weakness is related to utilization of health care resources in COPD patients. , 1997, The European respiratory journal.

[73]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[74]  W. MacNee,et al.  Systemic oxidative stress in asthma, COPD, and smokers. , 1996, American journal of respiratory and critical care medicine.

[75]  M. Decramer,et al.  Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[76]  R. Wolfe,et al.  Prolonged bed rest decreases skeletal muscle and whole body protein synthesis. , 1996, The American journal of physiology.

[77]  J. Curtis,et al.  Emergent assessment and management of acute respiratory failure in COPD. , 1994, Clinics in chest medicine.

[78]  K. Pandolf,et al.  Adductor pollicis muscle fatigue during acute and chronic altitude exposure and return to sea level. , 1994, Journal of applied physiology.

[79]  M. Decramer,et al.  Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered. , 1992, The European respiratory journal.

[80]  J. Moxham,et al.  Effect of acute hypercapnia on limb muscle contractility in humans. , 1990, Journal of applied physiology.

[81]  S C Gandevia,et al.  Inspiratory and skeletal muscle strength and endurance and diaphragmatic activation in patients with chronic airflow limitation. , 1989, Thorax.

[82]  E. Fiaccadori,et al.  Intracellular acid-base and electrolyte metabolism in skeletal muscle of patients with chronic obstructive lung disease and acute respiratory failure. , 1986, Clinical science.

[83]  P. Calverley,et al.  Effect of Carbon Dioxide on Diaphragmatic Function in Human Beings , 1984 .

[84]  A. Grassino,et al.  Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[85]  G. Hedenstierna,et al.  Muscle metabolism in patients with chronic obstructive lung disease and acute respiratory failure. , 1977, Clinical science and molecular medicine.